State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Am J Chin Med. 2011;39(6):1103-15. doi: 10.1142/S0192415X11009433.
Intestinal microbiota contribute to diverse mammalian processes including the metabolic functions of drugs. It is a potential new territory for drug targeting, especially for dietary herbal products. Because most herbal medicines are orally administered, the chemical profile and corresponding bioactivities of herbal medicines may be altered by intestinal microbiota. Ginseng is one of the most commonly used herbs and it is an attractive natural product to study its effect in the body. In this review, after briefly introducing the interactions of herbal products and gut microbiota, we discuss the microbiota-mediated metabolism of ginsenosides in ginseng and red ginseng. In particular, the major metabolite compound K and its pharmacological advances are described including anticancer, antidiabetic and anti-inflammatory effects. In summary, the intestinal microbiota may play an important role in mediating the metabolism bioactivity of herbal medicines.
肠道微生物群有助于多种哺乳动物过程,包括药物的代谢功能。它是药物靶向的一个潜在新领域,特别是对于膳食草药产品。由于大多数草药都是口服给药,草药的化学特征和相应的生物活性可能会被肠道微生物群改变。人参是最常用的草药之一,它是一种很有吸引力的天然产物,可用于研究其在体内的作用。在这篇综述中,在简要介绍了草药产品和肠道微生物群的相互作用之后,我们讨论了人参和红参中人参皂苷的微生物介导代谢。特别是,描述了主要代谢产物化合物 K 及其药理进展,包括抗癌、抗糖尿病和抗炎作用。总之,肠道微生物群可能在调节草药的代谢生物活性方面发挥重要作用。